Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

2M-euro grant for Crucell form Dutch govt.
September 26, 2005

Positive CPMP opinion for Pfizer's Macugen.(Committe for Proprietary M...
September 26, 2005

Lilly/Takeda's Actos PROactive study - a curate's egg of good, bad and...
September 26, 2005

Gene therapy boosted by "nanoscale" delivery to cancer cells...
September 26, 2005

Austria's Affiris makes progress on Alzheimer's vaccine.(Affris GmbH)(...
September 26, 2005

LEO Pharma and Warner Chilcott expand skin drug accord.(Leo Pharmaceut...
September 26, 2005

Alkermes' Risperdal Consta cleared in Italy.(Janssen-Cilag )(Brief Art...
September 26, 2005

Pharma concerns at UK reimbursement changes for branded generics, and ...
September 26, 2005

US reimbursement policies jeopardize off-label oncology drug use: indu...
September 26, 2005

Zyprexa stays on Florida Medicaid program.(Brief Article)
September 26, 2005

Indonesian drugmakers curb growth estimates.
September 26, 2005

Vietnam JV planning to export HIV/AIDS drugs.(Vietnam Stada Pharmacy)(...
September 26, 2005

Cytheris begins US Ph I trial of recombinant interleukin-7.(Brief Arti...
September 26, 2005

Esprit acquires Metagen Pharma group.(Esprit Pharma)(Brief Article)
September 26, 2005

Schering AG/Genzyme's Campath cuts MS relapse risk but has safety conc...
September 26, 2005

ALK-Abello's Grazax effective in rhinitis.(Brief Article)
September 26, 2005

Novartis indacaterol good in asthma/COPD.(chronic obstructive pulmonar...
September 26, 2005

Renovis announces public offering.(Brief Article)
September 26, 2005

UK Pharma Code of Conduct: 2004 report.
September 26, 2005

Hungarian pharma price, production news.(Brief Article)
September 26, 2005

Italian Health Minister's caution over new Rx law.(Francesco Storace)(...
September 26, 2005

Intercell starts Ph III trial of JE vaccine.(Japanese encephalitis)
September 26, 2005

AstraZeneca's Iressa boosts cancer survival.(Brief Article)
September 26, 2005

Spectrum Pharma completes $42M placing.(Spectrum Pharmaceuticals Inc.)...
September 26, 2005

Japan stock market week to Sept 19.
September 26, 2005

Australia's GroPep sees 536% net growth.(Brief Article)
September 26, 2005

S Africa's Enaleni buys FirstPharm.(Enaleni Pharmaceuticals acquires F...
September 26, 2005

Pharmagene to merge with Asterand.(Brief Article)
September 26, 2005

NIMH-funded study reviews use of antipsychotic medicines.
September 26, 2005

ProStrakan's first-half 2005 income jumps 78%.(Brief Article)
September 26, 2005

Allergy Thera's full-year sales rise 20%.(Allergy Therapeutics)(Brief ...
September 26, 2005

Pediatric British National Formulary launched.(Royal College of Paedia...
September 26, 2005

Novartis to exclusively develop terbinafine.
September 26, 2005

Forbes cholesterol drug shows early promise.(Forbes Medi-Tech Inc.)(Br...
September 26, 2005

UCB's Keppra PH III trial successful.
September 26, 2005

Roche's Herceptin trial yields positive results.
September 26, 2005

AstraZeneca publishes result of Nexium trial.
September 26, 2005

Genaera completes $24.5M financing.(Brief Article)
September 26, 2005

Calypte's Aware HIV test approved in Zimbabwe.(Calypte Biomedical Corp...
September 26, 2005

Mycogen prices $101M offering.(Brief Article)
September 26, 2005

Competition coming in sleep disorder mart.(Brief Article)
September 26, 2005

Pfizer's Lipitor, Celebrex top price rises for 96 drugs used by senior...
September 26, 2005

Janssen-Cilag's Topamax sees strong results for unmet need of migraine...
September 26, 2005

Roche/GSK's osteo drug, Bonviva, launched in UK.(GlaxoSmithKline launc...
September 26, 2005

EASD receive Novartis research grant.
September 26, 2005

GSK fined $150M by US Justice Dept.(GlaxoSmithKline PLC)
September 26, 2005

EMEA halts Hexavac sales on efficacy.(European Medicines Agency)(Brief...
September 26, 2005

Vietnam selects Rx firms.(Brief Article)
September 26, 2005

IFPMA launches first worldwide clinical trials portal.(International F...
September 26, 2005

Oxigene begins Ph II trials of cancer drug CA4P.(Combretastatin A4 Pho...
September 26, 2005

Eiffel and MAP enter collaboration accord.(Eiffel Technologies, MAP Ph...
September 26, 2005

Myriad's Flurizan sees good Ph II data.(Myriad Genetics Inc.)(Brief Ar...
September 26, 2005

Stock Commentary - New York week to sept 19.
September 26, 2005

Affymax initiates third Ph II Hematide trial.(Brief Article)
September 26, 2005

Aventis seeking prelim injunction against Barr over Allegra.(Aventis P...
September 26, 2005

John Lechleiter become Eli Lilly's COO.(chief operating officer)(Brief...
September 26, 2005

Wilex AG hires Norman Neville as VP, clinical R&D.(Brief Article)
September 26, 2005

Promotions at Par Pharma.(Par Pharmaceuticals Inc. appointed Michael G...
September 26, 2005

Neurobiologic Tech sells Xerecept rights to Celtic for $48M.(Neurobiol...
September 26, 2005

Pfizer disagrees with FDA's non-appro decision on parecoxib.(Bextra)(B...
September 26, 2005

UCB's Keppra gets EU approval.(UCB S.A.'s Keppara)(Brief Article)
September 26, 2005

Zonagen presents positive Proellex data.(Brief Article)
September 26, 2005

Health Canada approves Erbitux.(Bristol-Myers Squibb Canada and IMClon...
September 26, 2005

Genzyme initiates Myozyme study.(Brief Article)
September 26, 2005

Spectrum Pharma to raise $42M.(finance)(Brief Article)
September 26, 2005

ACADIA Pharma opens Swedish chemistry R&D facility.(Acadia Pharmaceuti...
September 26, 2005

Health Monitor debuts Educate to help on PhRMA guidelines.(Health Moni...
September 26, 2005

Abbott Labs' carotid stent gets US appro.(Abbott Laboratories Inc., Xa...
September 26, 2005

NicOx expands R&D accord with GFI.(NicOx S.A., Grupo Ferrer Internacio...
September 26, 2005

187% income drop widens Antisoma's full-year loss.(Antisoma PLC)(Brief...
September 26, 2005

GSK's Adartrel closer to EU approval.(GlaxoSmithKline PLC)(Brief Artic...
September 26, 2005

Centocor's Remicade cleared for ulcerative colitis in US.(Brief Articl...
September 26, 2005

Ranbaxy gets US clearance for zidovudine.(Ranbaxy Laboratories Ltd.)(B...
September 26, 2005

Elan and Biogen Idec update on Tysabri.(Biologics License Application)...
September 26, 2005

OSI/Roche's Tarceva gets EU approval.(OSI Pharmaceuticals Inc., Roche ...
September 26, 2005

Page 1|2|3|4|5|6|7